372 related articles for article (PubMed ID: 29855213)
1. Management of toxoplasmosis in transplant recipients: an update.
Dard C; Marty P; Brenier-Pinchart MP; Garnaud C; Fricker-Hidalgo H; Pelloux H; Pomares C
Expert Rev Anti Infect Ther; 2018 Jun; 16(6):447-460. PubMed ID: 29855213
[TBL] [Abstract][Full Text] [Related]
2. [Retrospective study of the implementation of the qualitative PCR technique in biological samples for monitoring toxoplasmosis in pediatric patients receiving hematopoietic stem cell transplantation].
Nigro MG; Figueroa C; Ledesma BA
Rev Argent Microbiol; 2014; 46(1):24-9. PubMed ID: 24721270
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and outcomes of toxoplasmosis among transplant recipients at two US academic medical centers.
Adekunle RO; Sherman A; Spicer JO; Messina JA; Steinbrink JM; Sexton ME; Lyon GM; Mehta AK; Phadke VK; Woodworth MH
Transpl Infect Dis; 2021 Aug; 23(4):e13636. PubMed ID: 33993599
[TBL] [Abstract][Full Text] [Related]
4. Toxoplasmosis in Pediatric Hematopoietic Stem Cell Transplantation Patients.
Schwenk HT; Khan A; Kohlman K; Bertaina A; Cho S; Montoya JG; Contopoulos-Ioannidis DG
Transplant Cell Ther; 2021 Apr; 27(4):292-300. PubMed ID: 33840441
[TBL] [Abstract][Full Text] [Related]
5. Myeloablative conditioning predisposes patients for Toxoplasma gondii reactivation after allogeneic stem cell transplantation.
Meers S; Lagrou K; Theunissen K; Dierickx D; Delforge M; Devos T; Janssens A; Meersseman W; Verhoef G; Van Eldere J; Maertens J
Clin Infect Dis; 2010 Apr; 50(8):1127-34. PubMed ID: 20218875
[TBL] [Abstract][Full Text] [Related]
6. Toxoplasmosis in Transplant Recipients, Europe, 2010-2014.
Robert-Gangneux F; Meroni V; Dupont D; Botterel F; Garcia JMA; Brenier-Pinchart MP; Accoceberry I; Akan H; Abbate I; Boggian K; Bruschi F; Carratalà J; David M; Drgona L; Djurković-Djaković O; Farinas MC; Genco F; Gkrania-Klotsas E; Groll AH; Guy E; Hirzel C; Khanna N; Kurt Ö; Junie LM; Lazzarotto T; Len O; Mueller NJ; Munoz P; Pana ZD; Roilides E; Stajner T; van Delden C; Villena I; Pelloux H; Manuel O
Emerg Infect Dis; 2018 Aug; 24(8):1497-1504. PubMed ID: 30014843
[TBL] [Abstract][Full Text] [Related]
7. Atypical strain of Toxoplasma gondii causing fatal reactivation after hematopoietic stem cell transplantion in a patient with an underlying immunological deficiency.
Stajner T; Vasiljević Z; Vujić D; Marković M; Ristić G; Mićić D; Pasić S; Ivović V; Ajzenberg D; Djurković-Djaković O
J Clin Microbiol; 2013 Aug; 51(8):2686-90. PubMed ID: 23761151
[TBL] [Abstract][Full Text] [Related]
8. Disseminated toxoplasmosis after allogeneic stem cell transplantation in a seronegative recipient.
Osthoff M; Chew E; Bajel A; Kelsey G; Panek-Hudson Y; Mason K; Szer J; Ritchie D; Slavin M
Transpl Infect Dis; 2013 Feb; 15(1):E14-9. PubMed ID: 23279790
[TBL] [Abstract][Full Text] [Related]
9. Low seroprevalence and low incidence of infection with Toxoplasma gondii (Nicolle et Manceaux, 1908) in pediatric hematopoietic cell transplantation donors and recipients: Polish nationwide study.
Czyzewski K; Fraczkiewicz J; Salamonowicz M; Pieczonka A; Zajac-Spychala O; Zaucha-Prazmo A; Gozdzik J; Styczynski J
Folia Parasitol (Praha); 2019 Nov; 66():. PubMed ID: 31823860
[TBL] [Abstract][Full Text] [Related]
10. Tissue and blood protozoa including toxoplasmosis, Chagas disease, leishmaniasis, Babesia, Acanthamoeba, Balamuthia, and Naegleria in solid organ transplant recipients- Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
La Hoz RM; Morris MI;
Clin Transplant; 2019 Sep; 33(9):e13546. PubMed ID: 30900295
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous acquired toxoplasmosis in a child: a case report and review of the literature.
Rand AJ; Buck AB; Love PB; Prose NS; Selim MA
Am J Dermatopathol; 2015 Apr; 37(4):305-10. PubMed ID: 24614207
[TBL] [Abstract][Full Text] [Related]
12. Guidelines for the management of Toxoplasma gondii infection and disease in patients with haematological malignancies and after haematopoietic stem-cell transplantation: guidelines from the 9th European Conference on Infections in Leukaemia, 2022.
Aerts R; Mehra V; Groll AH; Martino R; Lagrou K; Robin C; Perruccio K; Blijlevens N; Nucci M; Slavin M; Bretagne S; Cordonnier C;
Lancet Infect Dis; 2024 May; 24(5):e291-e306. PubMed ID: 38134949
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic hematopoietic stem cell transplant recipients and parasitic diseases: A review of the literature of clinical cases and perspectives to screen and follow-up active and latent chronic infections.
Fabiani S; Fortunato S; Petrini M; Bruschi F
Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28128496
[TBL] [Abstract][Full Text] [Related]
14. A prospective study of diagnosis of Toxoplasma gondii infection after bone marrow transplantation.
Edvinsson B; Lundquist J; Ljungman P; Ringdén O; Evengård B
APMIS; 2008 May; 116(5):345-51. PubMed ID: 18452424
[TBL] [Abstract][Full Text] [Related]
15. Toxoplasma prophylaxis in haematopoietic cell transplant recipients: a review of the literature and recommendations.
Gajurel K; Dhakal R; Montoya JG
Curr Opin Infect Dis; 2015 Aug; 28(4):283-92. PubMed ID: 26098500
[TBL] [Abstract][Full Text] [Related]
16. Acute exacerbation of Toxoplasma gondii infection after hematopoietic stem cell transplantation: five case reports among 279 recipients.
Sumi M; Aosai F; Norose K; Takeda W; Kirihara T; Sato K; Fujikawa Y; Shimizu I; Ueki T; Hirosima Y; Ueno M; Ichikawa N; Watanabe M; Kobayashi H
Int J Hematol; 2013 Aug; 98(2):214-22. PubMed ID: 23749548
[TBL] [Abstract][Full Text] [Related]
17. Toxoplasmosis in heart transplant recipients.
Gallino A; Maggiorini M; Kiowski W; Martin X; Wunderli W; Schneider J; Turina M; Follath F
Eur J Clin Microbiol Infect Dis; 1996 May; 15(5):389-93. PubMed ID: 8793397
[TBL] [Abstract][Full Text] [Related]
18. Serology for Toxoplasma in Immunocompromised Patients: Still Useful?
Dupont D; Fricker-Hidalgo H; Brenier-Pinchart MP; Garnaud C; Wallon M; Pelloux H
Trends Parasitol; 2021 Mar; 37(3):205-213. PubMed ID: 33046380
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and incidence of toxoplasmosis after autologous hematopoietic stem cell transplantation: A retrospective study and literature review.
Kitahara M; Hiroshima Y; Norose K; Hikosaka K; Kazumoto H; Uematsu N; Shishido T; Kaiume H; Sato K; Ueki T; Sumi M; Watanabe M; Kobayashi H
Transpl Infect Dis; 2021 Dec; 23(6):e13726. PubMed ID: 34542220
[TBL] [Abstract][Full Text] [Related]
20. Risk of reactivated toxoplasmosis in haematopoietic stem cell transplant recipients: a prospective cohort study in a setting withholding prophylaxis.
Štajner T; Vujić D; Srbljanović J; Bauman N; Zečević Ž; Simić M; Djurković-Djaković O
Clin Microbiol Infect; 2022 May; 28(5):733.e1-733.e5. PubMed ID: 34555535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
